Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IFLO is Breaking Out -- Ignore unavailable to you. Want to Upgrade?

To: Sergio H who wrote (894)	3/27/2000 9:17:00 AM
From: Carole	Read Replies (1) \| Respond to of 1018

Feeling pumped I-Flow Corp.'s new portable-infusion devices have profits and stock price high in its quest to be a takeover target. March 26, 2000 ocregister.com

To: Sergio H who wrote (894)	3/27/2000 11:24:00 AM
From: James Strauss	Read Replies (1) \| Respond to of 1018

Sergio: Here is something I posted on the Yahoo boards: {{{If we just used a very conservative $35.00 average profit for both Painbuster and On-Q, and we estimate only 10% market penetration of the estimated 39 million surgeries done in the U.S. each year, we get $35.00 x 3,900,000 = $136,500,000 in profit alone... That divided by about 14 million shares = $9.75 eps on just Painbuster and On-Q alone with just 10% market penetration in the U.S... Add the other products and international sales, and you have a potential stock price over $100.00 a share with a relatively low P/E around 10... Imagine what happens when IFLO starts using the internet to augment its marketing... I think we have a tiger by the tail... : > }}} Jim